Upcoming Webinars


Epitranscriptomics and Disease: The Role of RNA Modification in the Life Cycle of the Cell

JUNE 30, 2021Program | Sponsored by: Zobio

Prof. Sebastian Leidel, Professor for RNA Biochemistry, Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP)
University of Bern, Switzerland

Prof. Samie R. Jaffrey, M.D., Ph.D., Greenberg-Starr Professor of Pharmacology, The Department of Pharmacology
Weill Cornell Medicine, NYC

Dr. Gregg Siegal, CEO
ZoBio


Webinar Archives


Practical Strategies for Overcoming Challenges in the Development of AAV vectors for Gene Therapy

FEBRUARY 24, 2021Program | Sponsored by: NanoTemper

Santoshkumar L. Khatwani, PhD
Santoshkumar L. Khatwani, PhD, Associate Director, Analytical Development
Sangamo Therapeutics

Xiaoying Jin, PhD
Greenberg-Starr Professor of Pharmacology
Senior Principal Scientist
Sanofi


Understanding the Nuances of Targeted Protein Degradation

DECEMBER 10, 2020Program | Sponsored by: NanoTemper

Stewart Fisher, PhD
Chief Scientific Officer
C4 Therapeutics

Alessio Ciulli, PhD
Professor of Chemical and Structural Biology, School of Life Sciences
University of Dundee


Drug Discovery Powered by HUB Organoids

OCTOBER 26, 2020Program | Sponsored by: HUB

Robert Vries, PhD
CEO
Hubrecht Organoid Technology (HUB)


The Role of 3D in the Fight Against SARS-CoV-2: Using Organoids for COVID-19 Disease Models and Organoid Best Practices

OCTOBER 21, 2020Program | Sponsored by: Corning

Shuibing Chen, PhD
Kilts Family Associate Professor, Director of Diabetes Program, Department of Surgery
Weill Cornell Medicine

Austin Mogen, PhD
Senior Field Application Scientist
Corning Life Sciences


Researching and Targeting Tumor Microenvironment: New Frontline in Immuno-Oncology Research

SEPTEMBER 30, 2020Program | Sponsored by: AIM Biotech MilliporeSigma

Russell W. Jenkins, MD, PhD
Assistant Professor
Dept. of Medicine, Center for Cancer Research, Massachusetts General Hospital

Viviana Cremasco, PhD
Investigator III, Exploratory Immuno-Oncology
Novartis

Pushpa Jayaraman, PhD
Senior Investigator I, Exploratory Immuno-Oncology
Novartis Institutes for Biomedical Research

Chairperson: Kuan Chee Mun
CEO
AIM Biotech


Formulation and Stability Screening of Biotherapeutics

SEPTEMBER 23, 2020Program | Sponsored by: Nanotemper

Charles Heffern
Product Manager, NanoTemper

Jie Wen
Senior Scientist, Higher Order Structure, Biological Relevance and Characterization, Attribute Sciences Amgen, Thousand Oaks


Novel Drug Modalities & Integrated Platforms to Transform R&D Productivity

JULY 16, 2020Program | Sponsored by: Research Solutions / Reprints Desk

James (Jay) Bradner, MD, President
Novartis Institutes for BioMedical Research (NIBR)

Mitja-Alexander Linss
Director of Marketing at Research Solutions
Reprints Desk

Tomi K Sawyer, PhD
President & Chief Drug Hunter, Maestro Therapeutics
Individual Consultant

Anabella Villalobos, PhD
Senior Vice-President, Biotherapeutics and Medicinal Sciences
Biogen